Navigation Links
CIS Generic & Innovative Drug Market - 2015 Forecast Russia, Ukraine & Kazakhstan New Research Report at

Dallas, TX (PRWEB) May 09, 2013

Keep current with the changing CIS generic and innovative drug segments.

Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015.

Generic and innovative drug segments in CIS countries have played a huge role in supporting the pharmaceutical industry. Meanwhile, the effects of programmes such as Russia’s Pharma 2020, Kazakhstan’s GMP initiative and Ukraine’s updated reimbursement structure are visible in the marketplace.

How will issues like these influence market development in the next few years? How will they change pricing structures and reimbursement schemes? What are the rules regarding data exclusivity periods and drug patent viability?

Stay informed with regard to these topics and many more by reviewing Generic and innovative drugs market in CIS countries 2013, Russia, Ukraine and Kazakhstan, Development forecasts for 2013-2015. This authoritative report is a single and complete source of market data, analysis and forecasts, combined to serve the needs of professionals with interests in the market.

This report “Generic and innovative drugs market in CIS countries 2013. Russia, Ukraine and Kazakhstan” includes all relevant data concerning the size and value of the generic and innovative drugs markets in Russia, Ukraine and Kazakhstan. The document enables users to perform comparative analysis of market conditions in each country quickly and simply. It provides market share data for these drug segments in each of the three countries, highlights the top selling products, and profiles the companies that lead the region in the production and sale of generic and innovative preparations. The report takes a look at the future of the markets, predicting the effects of trends and regulatory actions on growth and development in carefully constructed forecasts that span the period 2013-2015.

Each country is closely examined in terms of its regulatory environment. Reimbursement structures and listing procedures are defined, along with drug patent regulations and data exclusivity periods. Pricing criteria, including VAT rates on medicines and price mark-ups and the variations in rules from country to country are explained. PMR has collected information from a wide variety of reliable sources and combined it to create a single convenient and easy-to-use document that enables industry professionals to perform critical tasks with accuracy and confidence in their business success.

Whether investigating CIS data on the generic and innovative drug market - while considering possible entry, creating or expanding a portfolio of products or providing financial or consulting services to businesses engaged in the CIS markets, Generic and innovative drugs market in CIS countries 2013, Development forecasts for 2013-2015 provides solid informational support. PMR clients consult the report when monitoring changing reimbursement lists and procedures, preparing a corporate growth strategy, locating investments, preparing corporate reports and keeping up with regulatory changes in the CIS region.

Buy a copy of report @

Explore more reports on Pharmaceutical Market @

About Us ( is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Active Pharmaceutical Ingredients (API) Market in Europe Will Reach $38,255.67 Million By 2017- Pricing and Reimbursement Initiatives Supporting Generic Drug Growth
2. Heart Attack Preventing Drug, Plavix, Poses Continued Risk While Bristol-Myers Squibb Extends the Rights to Others for Generic OTC Versions
3. Richard W. Schulte of Wright & Schulte LLC: a Tireless Fighter for Victims of Generic Drug Labeling Practices
4. Darvone-Darvocet Failure to Warn Claims Reinstated against Generic Drug Maker Wright & Schulte LLC Report
5. Drug Makers Get EU Complaint over Generic Fentanyl Delay: Now, AttorneyOne Can Provide Advice for Legal Counsel in Case of Side Effects
6. Hoping to Ease Shortage, FDA Fast-Tracks Generic Form of Cancer Drug
7. Generic HIV treatment strategy could save nearly $1 billion annually but may be less effective
8. 1/3 of Docs Often Prescribe Brand-Name Drugs Over Generics: Study
9. People May Skip Generic Pills if Color Differs From Brand-Name Drug
10. Differences in generic pill characteristics may lead to interruptions in essential medication use
11. Inconsistency Seen in Safety Labeling for Generic Drugs
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: